Codeine and oxycodone use in patients with chronic rheumatic disease pain

Area of Science:

• Rheumatology
• Pain Management
• Pharmacology

Background:

• Opioid use for chronic rheumatic disease pain is debated due to concerns about efficacy, toxicity, and abuse.
• This study investigates opioid efficacy and safety in patients with defined rheumatic conditions.

Purpose of the Study:

• To examine opioid use in a cohort of patients experiencing pain from defined rheumatic diseases.
• To assess the efficacy, toxicity, and patterns of opioid use in this population.

Main Methods:

• Retrospective study of 644 rheumatology patients using pharmacy and medical records.
• Patient interviews were conducted to assess pain relief, side effects, and substance abuse history.
• Opioid prescriptions, dosage changes, and reasons for escalation were analyzed.

Main Results:

• Opioids significantly reduced pain severity scores (8.2 to 3.6 on a 0-10 scale).
• Mild side effects (nausea, constipation, sedation) were reported in 38% of patients.
• Dosage escalations were primarily due to worsening of the underlying rheumatic condition, not opioid tolerance.

Conclusions:

• Prolonged treatment with codeine or oxycodone is effective for rheumatic disease pain with minimal toxicity.
• Stable opioid doses and escalations linked to disease progression suggest tolerance is not a primary issue.
• Concerns regarding opioid efficacy, toxicity, and abuse should not preclude their use in well-defined rheumatic pain cases.